Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm.

Romanelli, Kristen; Wells, Justin; Patel, Aneeta; Mendonca Torres, Maria; Costello, John; Jensen, Kirk; Vasko, Vasyl

Romanelli, Kristen; Wells, Justin; Patel, Aneeta; Mendonca Torres, Maria; Costello, John; Jensen, Kirk; Vasko, Vasyl.

Afiliación

Romanelli K; Department of Pediatric, Hematology/Oncology, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Wells J; Department of Pathology, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Patel A; Department of Pediatrics, Uniformed Services University of Health Sciences, Bethesda, MD, USA.
Mendonca Torres M; Department of Pediatrics, Uniformed Services University of Health Sciences, Bethesda, MD, USA.
Costello J; Department of Pediatrics, Uniformed Services University of Health Sciences, Bethesda, MD, USA.
Jensen K; Department of Pediatrics, Uniformed Services University of Health Sciences, Bethesda, MD, USA.
Vasko V; Department of Pediatrics, Uniformed Services University of Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.

Ther Adv Endocrinol Metab ; 12: 20420188211058327, 2021.

Article en En | MEDLINE | ID: mdl-35154635

Palabras clave

mutations; oncogenes; radiation; second malignant neoplasm; thyroid cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Endocrinol Metab Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google